20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • Scientific Indexing Services (SIS)
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image
Albumin-gold nanorods based core-shell nanoplatforms for cancer theranostics
11th International Conference and Expo on Nanoscience and Molecular Nanotechnology
October 20-22, 2016 Rome, Italy

Hsien Ting Chiu, Chung Hao Chen, Meng Lin Li, Chi Shiun Chiang and Yu Feng Huang

National Tsing Hua University, Taiwan

Scientific Tracks Abstracts: J Nanomed Nanotechnol


Over the past two decades, the rapid development of albumin- and gold nanostructures-based nanoplatforms offer promising solutions to address numerous scientific difficulties in cancer research such as drug delivery, tumor targeting and cancer therapy. In this study, a hybrid system (NR@SA) was designed for theranostic nanomedicine through chemically cross-linking of serum albumin (SA) shell outside the core of gold nanorod (Au NR). A tremendous amount of anticancer drugs, doxorubicin (DOX) could also be encapsulated inside the SA shell via physical adsorption during the formation of NR@SA:DOX. Our results demonstrated that the SA shell exhibited a great impact on the photoacoustic signal generation, leading to a strong contrast enhancement in photoacoustic imaging of tumor cells. Delivered NR@SA:DOX with higher DOX loading exhibited greater killing efficacy while the photothermal effect induced by the near-infrared laser irradiation also greatly improved the therapeutic efficacy of DOX against tramp-C1 prostate carcinoma in vitro and in vivo. These findings suggest that the development of core-shell nanoplatform, NR@SA is highly promising as an integrated theranostic nanoagent for further clinical applications.

Biography :

Hsien Ting Chiu has completed his Bachelor’s degree from National Tsing Hua University at the Department of Biomedical Engineering and Environmental Sciences in 2012. He is now a PhD student in National Tsing Hua University in the Department of Biomedical Engineering and Environmental Sciences. His research is focused on nanomaterial design for cancer application.

Email: haha4301292@yahoo.com.tw